Pre-eclampsia and the foetus: a cardiovascular perspective.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Perinatal Health

Background:

• Pre-eclampsia is a major cause of maternal and infant mortality.
• Understanding its pathogenesis is crucial for developing interventions.
• Two distinct mechanisms, absolute and relative utero-placental ischemia, are implicated in early- and late-onset pre-eclampsia, respectively.

Purpose of the Study:

• To elucidate the pathogenic mechanisms of early- and late-onset pre-eclampsia.
• To explore advancements in prediction, screening, and intervention strategies.
• To highlight the importance of early detection and targeted management.

Main Methods:

• Investigating maternoplacental circulation and placental hormones in first and second trimesters for screening.
• Utilizing low-dose aspirin prophylaxis before 16 weeks' gestation for high-risk first-trimester pregnancies.
• Employing cardiac Doppler, multi-vessel fetal Doppler, and biomarkers in the third trimester for outcome prediction.

Main Results:

• Early screening identifies high-risk pregnancies for targeted interventions.
• First-trimester screening allows for prophylactic low-dose aspirin, significantly reducing severe early-onset pre-eclampsia.
• Second-trimester screening enables focused management strategies.
• Third-trimester assessments predict adverse outcomes and guide delivery timing.

Conclusions:

• Advances in understanding pre-eclampsia pathogenesis have improved prediction and screening.
• Early identification and intervention, such as low-dose aspirin, can substantially reduce severe disease.
• Continued research into this condition promises further prophylactic and therapeutic breakthroughs.